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New viral infections in humans usually result from Results and discussion
Although productive infection of primate cells by FIV hasviruses that have been transmitted from other
species as zoonoses. For example, it is accepted been demonstrated in vitro [2, 7, 8], transmission of the
virus to primates by natural infection has not been docu-widely that human immunodeficiency virus (HIV) is
the result of the propagation and adaptation of a mented. To assess the ability of FIV to infect primate cells
in vivo, we isolated primary peripheral bloodmononuclearsimian immunodeficiency virus (SIV) from
nonhuman primates to man [1]. Previously, we cells (PBMC) from two adult cynomolgus macaques and
infected them with a virus derived from the Petalumareported productive infection of primary human
cells in vitro by feline immunodeficiency virus (FIV) strain of FIV, as described previously [2]. After 3 days,
FIV replication was confirmed by a reverse transcriptase[2], a lentivirus that causes an immunodeficiency
syndrome in cats similar to HIV in humans [3]. The (RT) assay [2], and infected PBMC (4 106) were re-
turned to the same donor by intravenous transfusion inpresent study extends these findings by
demonstrating that cynomolgus macaques (Macaca 3 ml phosphate-buffered saline. This protocol was chosen
for several reasons. First, the transmission of FIV underfasicularis) infected with FIV exhibited clinical
signs, including depletion of CD4 cells and weight natural conditions primarily involves a bite that introduces
free viruses and infected cells directly into the blood-loss, that are consistent with FIV infection. The
development of an antibody response to FIV gag- stream of the new host [3]. Second, viral stocks produced
in a recipient animal’s own PBMC (such stocks are termedencoded proteins and detection of virus-specific
sequences in sera, blood-derived cells, and an autologous virus) have been shown to result in higher
viral loads and more severe pathologies than nonautolo-necropsied tissue accompanied these changes.
Moreover, the reactivation of FIV replication from gous lentiviral preparations [9]. Moreover, FIV derived
from feline cells would contain envelope glycoproteinslatently infected cells was observed after
stimulation in vitro with phorbol esters and in vivo expressing galactosyl (1-3)galactosyl (Gal). Since pri-
mates produce natural antibodies against this sugar, com-with tetanus toxoid. The proposed use of
lentiviruses in human gene therapy [4, 5] and of plement-mediated inactivation would likely reduce the
potential for in vivo infection of primate cells by FIVnonhuman cells and organs in xenotransplantation
[6] has raised concerns about zoonoses as potential produced by nonprimate cells [10]. Finally, the use of
PBMC that were productively infected with FIV allowedsources of new human pathogens. Therefore, the
study of FIV infection of primate cells may provide the delivery of the virus in a manner that circumvented
the low titers of cell-free virus obtained fromFIV-infectedinsight into the principles underlying retroviral
xenoinfections. primate PBMC [2].
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reduction of 72.3% at week 6 for CM1SP, while the level
of CD8 cells was elevated over the same period (Figure
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Figure 1 the primary targets of FIV in its feline host [3], also repre-
sented the principal primate cell type infected in vivo.
Moreover, the severity of the CD4 cell depletion ob-
served in FIV-infected macaques indicated that FIV in-
fection was highly toxic to select primate cells in vivo.
For the confirmation of the in vivo infection of primate
cells by FIV, the presence of the FIV pol gene in blood
and tissue was assessed by nested PCR and RT-PCR
amplification of genomic DNA and total cellular RNA,
respectively, with the primers and conditions described
previously [2]. Although FIV was not detectable in either
macaque prior to infection (week 0), FIV-specific se-
quences were detected in PBMC from CM1SP until 9
weeks and in CM2ST until 4 weeks (Figure 2a). Similarly,
RT-PCR revealed the presence of FIV RNA in sera col-
lected from each animal over the same period, although
viral sequences were only detectable for 4 weeks in
CM1SP and 2 weeks in CM2ST (Figure 2a). An analysis
of necropsied tissue from each macaque demonstrated
that FIV sequences were also present in RNA and DNA
isolated from spleen from CM1SP and in RNA from both
lymph node and spleen tissue from CM2ST, but not in
any other tissues investigated (Figure 2b). It is unlikely
that these results represented residual cells from the initial
transfusion of infected PBMC. Animals were transfused
with only 4  106 cells, of which approximately 10%
were infected [2], and the cytotoxicity associated with
FIV infection would have reduced this number further.
In addition, the abundance of viral DNA detected in
PBMC varied over the time course, and this variation
indicates changes in the number of infected cells.
FIV infection is associated with weight loss and depletion of CD4
cells. Cynomolgus macaques were infected with FIV, body weight was The above findings extended earlier in vitro results by
measured, and blood, from which mononuclear cells were isolated,
demonstrating that FIV could infect nonhuman primatewas harvested at successive weeks PI. The same parameters were
cells in vivo and induce symptoms characteristic of FIVassessed for 6 weeks before infection. CM2ST received intramuscular
injections of tetanus toxoid (0.25 ml) at weeks 9 and 10 PI (arrows), infection. However, differences were observed between
while CM1SP remained untreated after the initial infection. (a) Weight hosts. Although CM1SP exhibited sustained weight loss
loss, expressed as a percentage of the initial weight of each macaque
and CD4 cell depletion over the 12 week period, these(approximately 28 pounds), was observed with both animals and
parameters were decreased only transiently for CM2STreached maximal values of 11%–20%. (b) CD4 and CD8 cell
levels in mononuclear cells isolated at each time point were determined and began to return to preinfection values after week 3
by flow cytometry. Results are expressed as percent changes relative (Figure 1). Similarly, FIV remained detectable in the se-
to the abundance of CD4 (approximately 20%) and CD8
rum and PBMC of CM1SP for a longer period of time(approximately 30%) cells detected in each animal prior to infection.
than CM2ST (Figure 2), and this result suggests thatCells incubated either in the absence of antibodies or with 1 g/ml
of isotype-matched murine IgG1 served as controls for each animal. CM2ST was able either to clear the virus or to control
A marked decline in CD4 cells exceeded 70% and was detected the infection more efficiently. Since latent infection of
in both animals. primate cells has been observed in vitro [12], the question
of viral persistence was addressed by the stimulation of
PBMC isolated from each macaque with phorbol-12-
myristate-13-acetate (PMA; Sigma, Oakville, Ontario,1b). No change in the level of CD8 cells was observed
for CM2ST, but CD4 levels decreased by 76.5% within Canada). Like primate lentivirus genomes, the Petaluma
genome contains promoter elements that bind phorbolthe first 3 weeks PI (Figure 1b). Compared to preinfection
values, monocyte and neutrophil levels were decreased ester-activated transcription factors, such as members of
the activated protein (AP)-1 family [13]. Although FIVby 10% and 5%, respectively, after infection in both ma-
caques, but the abundance of these cells did not vary over was not detectable by RT-PCR analysis of PBMC har-
vested from CM2ST at week 6 PI, viral RNA (Figure 2c)the time course. These results suggested that CD4 cells,
Brief Communication 1111
Figure 2 and elevated RT activity (not shown) were detected in
cultures of these cells after stimulation with PMA. Similar
results were observed with PBMC obtained from CM1SP
at week 12 PI (Figure 2c) and suggest that latently in-
fected cells persisted in both animals. To investigate this
hypothesis in vivo, CM2ST was immunized at weeks 9
and 10 PI with tetanus toxoid (TTX; Connaught Labs,
Seattle, Washington), a compound shown previously to
activate lentiviral replication in latently infected cells [14].
Following treatment with TTX, weight loss was observed
again in CM2ST and had decreased approximately 10%
by week 12 PI (Figure 1a). Although a similar decline in
CD4 cells was not detected in these cells, the increase
that had been observed from week 3 to week 9 was ar-
rested (Figure 1b). Moreover, FIV genome, which was
not detectable in either PBMC or serum beyond 4 weeks
PI before CM2ST was immunized, was again detected
at week 12 (Figure 3a). These results indicate that FIV
persisted in immunocompetent primate hosts at levels
below the limit of detection of the PCR protocol (approxi-
mately 10 copies [2]) for a minimum of 3 months after
initial exposure to the virus. Moreover, an activating stim-
ulus could induce further replication and spread of the
virus.
Because numerous host factors, such as virus-specific im-
mune responses, influence the persistence of lentiviruses
in vivo, the production of anti-FIV antibodies by infected
macaques was investigated by Western blot analysis [15].
Using sera collected from CM2ST at weeks 6 and 12 PI
as sources of antibodies, we detected prominent bands at
25 kDa and 55 kDa in protein extracts derived from the
blood of a Petaluma-infected adult cat, with additional
bands observed at higher molecular weights (Figure 3b
and 3c). Similar bands were detectable in protein extracts
Detection of FIV-specific sequences in infected macaques. fromDH5 bacteria expressing Petaluma gag-encoded pro-Necropsied tissue, PBMC, and sera were harvested from FIV-
teins but not in protein isolated from untransformedinfected macaques, and genomic DNA and total RNA, from which
cDNA was prepared, were isolated. The presence of viral sequences DH5 bacteria. A monoclonal antibody raised against the
was determined by nested PCR amplification and Southern blot Petaluma p25 capsid protein (clone 43-1E2; kindly pro-
detection of the FIV pol gene. Amplification of a water blank (W) vided by Dr. N. Pedersen, University of California, Davis,and the GAPDH gene served as controls for contamination and equal
California) detected the same bands at 25 kDa and 55template loading, respectively. Representative blots from three
reactions are shown. (a) PCR analysis detected FIV sequences for kDa (Figure 3d). These findings suggest that antibodies
up to 9 weeks in PBMC and 4 weeks in serum isolated from CM1SP. against the FIV p25 capsid protein and the p55 Gag poly-
FIV sequences were detected for up to 4 weeks in PBMC and 2 protein were present in serum from CM2ST. No immu-
weeks in serum isolated from CM2ST. After treatment with tetanus
noreactivity was detected with serum collected fromtoxoid at weeks 9 and 10 PI, viral sequences were again found in
CM2ST before infection (Figure 3a) or from CM1SP atPBMC and in serum from CM2ST. (b) Bone marrow (BM), bowel
(B), brain (BR), kidney (K), lung (L), lymph node (LN), and spleen (S) any of the time points (not shown). These findings indi-
tissue was harvested at week 12 PI. Lymph nodes were obtained cate that antibody responses to FIV varied between host
from the bowel and were remote from the site of injection. FIV
animals and suggest that, compared to the sustainedsequences were detected in genomic DNA and RNA isolated from
changes exhibited by CM1SP, the transient CD4 cellspleen tissue from CM1SP and in RNA isolated from spleen and lymph
node from CM2ST. (c) PBMC were isolated from CM1SP and depletion and weight loss observed with CM2ST may
CM2ST at weeks 12 and 6, respectively, and cultured for 48 hr in have resulted from differences in the ability to mount an
the presence () or absence (-) of PMA (50 ng/ml). RNA isolated
adaptive immune response and control the spread of thefrom FIV-infected feline PBMC (C) and from each PBMC preparation
virus. This concept is supported by previous reports thatprior to the creation of cDNA () served as controls. PMA stimulation
induced FIV gene expression in PBMC harvested from either animal. a rapid and sustained decrease, analogous to that observed
with CM1SP, in circulating CD4 cells abrogates the
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Figure 3
Detection of anti-FIV antibodies in sera from
infected macaques. Protein extracts were
prepared from cultures of DH5 bacteria
transformed with plasmids encoding FIV gag-
encoded polyproteins (capsid), separated by
SDS-PAGE, and transferred to nitrocellulose
membranes. Protein isolated from
nontransformed DH5 cells (-C) and blood
from a FIV-infected adult cat (C) served as
negative and positive controls, respectively.
Representative immunoblots from three
experiments for each time point are shown.
(a,b,c) Membranes were incubated with
serum (1:10 dilution) collected from each
FIV-infected macaque at weeks (a) 0, (b) 6,
and (c) 12 PI. Immunoreactivity was
observed with the use of serum collected from
CM2ST at weeks 6 and 12 PI as a source
of antibodies (shown), but no such
immunoreactivity was observed with serum
collected from CM1SP at any of the time-
points (data not shown). (d) Membranes
were incubated with a monoclonal antibody
raised against the FIV p25 capsid protein.
ability of macaques infected with simian-human immuno- to suggest that FIV represents a health hazard. For exam-
ple, the design of the current study circumvents many ofdeficiency viruses (SHIV) to develop a detectable anti-
body response against the virus, whereas a marked but the natural barriers to cross-species infection by FIV,
while the small number of animals used makes definitivetransient decrease in CD4 cells still allows for rapid
seroconversion [9, 16]. However, only antibodies to FIV conclusions about the properties of FIV infection of pri-
mate cells difficult. However, in the context of xenotrans-gag-encoded proteins were investigated in the present
study, and it is conceivable that antibodies to other FIV plantation and gene therapy based on viral vectors, the
transmission barriers between animal viruses and humansantigens were present in sera from CM1SP. In addition,
seroconversion may have been observed if the infection are also greatly reduced due to immunosuppressive thera-
pies designed to prevent rejection of the foreign tissuehad been followed beyond 12 weeks or the animal had
been treated with tetanus toxoid, which would stimulate or adverse immune responses to the vector [6]. Thus, FIV
may provide a model for assessing the mechanisms byFIV replication.
which lentivirus xenoinfections emerge.
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